---
category: listing
circular_id: b592bceabbd25153
date: '2026-02-26'
description: BSE notice announcing the listing and commencement of trading for equity
  shares of Gaudium IVF and Women Health Limited on the BSE exchange.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={ADF0D927-ADF2-41E5-B7D1-4657756A86C9}&noticeno=20260226-41&dt=02/26/2026&icount=41&totcount=49&flag=0
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: Standard equity listing circular for a new SME healthcare company (IVF
  and women health services) being admitted for trading on BSE; relevant to investors
  interested in the healthcare and fertility sector.
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20260226-41&attachedId=f9c5a607-13b1-418d-a0ae-1da48e5fb25f
processing:
  attempts: 1
  content_hash: 76a5f909c7f4dfae
  processed_at: '2026-02-26T21:39:18.844426'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2026-02-26T14:06:02+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={ADF0D927-ADF2-41E5-B7D1-4657756A86C9}&noticeno=20260226-41&dt=02/26/2026&icount=41&totcount=49&flag=0
severity: medium
source: bse
stocks:
- GAUDIUM
tags:
- listing
- equity-shares
- ipo
- healthcare
- ivf
- women-health
- sme
- new-listing
title: Listing of Equity Shares of GAUDIUM IVF AND WOMEN HEALTH LIMITED
---

## Summary

BSE has issued a notice for the listing and commencement of trading of equity shares of Gaudium IVF and Women Health Limited on the BSE exchange. The circular provides details of the scrip code, ISIN, trading group, face value, lot size, and the effective date from which the shares will be available for trading.

## Key Points

- Equity shares of Gaudium IVF and Women Health Limited admitted for trading on BSE
- Company operates in the IVF (In Vitro Fertilization) and women's healthcare sector
- BSE Notice No.: 20260226-41 dated February 26, 2026
- Shares to be traded in the applicable BSE market segment
- ISIN and scrip code assigned for trading purposes

## Regulatory Changes

No material regulatory changes. This is a standard listing notice pursuant to an IPO/offer by the company, granting the equity shares admission to dealing on BSE in accordance with BSE Listing Regulations and SEBI (ICDR) Regulations.

## Compliance Requirements

- Market participants may trade in equity shares of Gaudium IVF and Women Health Limited from the effective trading date
- Trading to be conducted under the applicable BSE group classification (likely T or XT group for new listings)
- Special Pre-Open Session (SPOS) may be applicable for price discovery on the first day of trading as per SEBI circulars
- Members/brokers are required to note the scrip details and ISIN for order entry purposes

## Important Dates

- **February 26, 2026**: Date of BSE circular/notice
- **Trading commencement date**: As specified in the circular (expected within 1-2 trading days of notice)

## Impact Assessment

### Market Impact
- New listing adds a healthcare/fertility services company to BSE's equity market
- Gaudium IVF and Women Health Limited operates in the growing IVF and reproductive medicine sector in India
- Investors in the healthcare and women's health segment gain a new investment option

### Trading Impact
- Shares will be subject to applicable price band restrictions on the first day of listing
- Trade-to-Trade (T2T) restrictions may apply if classified under XT or T group
- Special Pre-Open Session applicable for price discovery on listing day

### Sector Significance
- Addition to BSE's healthcare segment in the fertility/IVF niche
- Reflects growing investor interest in specialised women's healthcare services in India